{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:55:28Z","timestamp":1779350128214,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.transproceed.2013.10.040","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T08:30:49Z","timestamp":1391589049000},"page":"66-74","source":"Crossref","is-referenced-by-count":18,"title":["Sirolimus for Treatment of Autosomal-Dominant Polycystic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"46","author":[{"given":"Y.-M.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.Q.","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2013.10.040_bib1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","article-title":"Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota","volume":"2","author":"Iglesias","year":"1983","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.transproceed.2013.10.040_bib2","first-page":"252","article-title":"Molecular genetics of autosomal dominant polycystic kidney disease","volume":"26","author":"Pei","year":"2003","journal-title":"Clin Invest Med"},{"issue":"4","key":"10.1016\/j.transproceed.2013.10.040_bib3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s10157-012-0611-9","article-title":"Renal disease progression in autosomal dominant polycystic kidney disease","volume":"16","author":"Higashihara","year":"2012","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"10.1016\/j.transproceed.2013.10.040_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ijc.21932","article-title":"Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells","volume":"119","author":"Beevers","year":"2006","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.transproceed.2013.10.040_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"14","key":"10.1016\/j.transproceed.2013.10.040_bib6","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"10.1016\/j.transproceed.2013.10.040_bib7","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1016\/j.transproceed.2009.05.032","article-title":"Sirolimus therapy for patients with adult polycystic kidney disease: a pilot study","volume":"41","author":"Soliman","year":"2009","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.transproceed.2013.10.040_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","author":"Perico","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.transproceed.2013.10.040_bib9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.transproceed.2013.10.040_bib10","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1093\/ndt\/gfs264","article-title":"Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study","volume":"27","author":"Stallone","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.transproceed.2013.10.040_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/ndt\/gfs519","article-title":"mTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): the\u00a0question remains open","volume":"28","author":"Jardine","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"20","key":"10.1016\/j.transproceed.2013.10.040_bib12","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.transproceed.2013.10.040_bib13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.transproceed.2013.10.040_bib14","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1016\/j.transproceed.2012.06.073","article-title":"Sirolimus produced S-shaped effect on adult polycystic kidneys after 2-year treatment","volume":"44","author":"Soliman","year":"2012","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.transproceed.2013.10.040_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.ajkd.2009.09.004","article-title":"Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial","volume":"55","author":"Franz","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.transproceed.2013.10.040_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.trre.2011.10.003","article-title":"mTOR inhibitor-associated proteinuria in kidney transplant recipients","volume":"26","author":"Diekmann","year":"2012","journal-title":"Transplant Rev (Orlando)"},{"issue":"6","key":"10.1016\/j.transproceed.2013.10.040_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/MAJ.0b013e318256754f","article-title":"Efficacy and safety of mTOR inhibitor therapy in patients with early-stage autosomal dominant polycystic kidney disease: a meta-analysis of randomized controlled trials","volume":"344","author":"He","year":"2012","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.transproceed.2013.10.040_bib18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/17425255.4.6.807","article-title":"Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials","volume":"4","author":"S\u00e1nchez-Fructuoso","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513010919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513010919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T21:52:09Z","timestamp":1538862729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134513010919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0041134513010919"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2013.10.040","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}